Latest filing published 04 Sept 2026 for Actinium Pharmaceuticals, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -24.1%Entry US$59.70 · Close at T+365 US$45.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
C. David Nicholson: trading record in brief
This profile gathers the share dealings of C. David Nicholson in Actinium Pharmaceuticals, Inc. Between 14 April 2016 and 2 September 2026, the trades on record add up to 2 filings.
Every open-market trade on record is a purchase: 1 purchase worth €8,873, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant.
On 4 September 2026 came the latest disclosure, a share grant in Actinium Pharmaceuticals, Inc. The clock since the last published purchase (18 April 2016) now reads 3,856 days. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to C. David Nicholson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 62,800 shares0Common StockSEC:0001213900-26-097745:0
- 5,000 shares@ US$2.00100.0% of flowCommon StockSEC:0001213900-16-012635:0Canonical exit: 13 Jul 2016 (T+90)
2 of 2 declarations